Glenmark and Ichnos take a collaborative leap to accelerate innovation in Cancer Treatment

 Mumbai, India, January 31, 2024: Glenmark Pharmaceuticals Ltd. (Glenmark), a leading, research-driven, global pharmaceutical company, and Ichnos Sciences Inc. (Ichnos), its global fully integrated, clinical-stage biotech subsidiary, today announced the launch of their alliance – Ichnos Glenmark Innovation – to accelerate new drug discovery in cancer treatment. This alliance combines Glenmark’sresearch and development proficienciesin small …